Power Law company profile

Crinetics Pharmaceuticals

Biotech & Life Sciences · San Diego, United States · Founded 2008 · IPO 2018 Unicorn

Novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers

Valuation

$3.11B

Market cap · May/2026

Revenue

$7.7M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

15 investors on Crinetics Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

5AM Ventures

Versant Ventures

Vivo Capital

Series B+ 12 investors entered at this stage

RA Capital Management

Driehaus Capital Management

GordonMD Global Investment

Janus Henderson Investors

Adage Capital

OrbiMed

EcoR1 Capital

Invus

Perceptive Advisors

Rock Springs Capital

First Light Asset Management

Paradigm BioCapital

Global footprint

Where Crinetics Pharmaceuticals has talent and traffic

Workforce by country

8 countries with
team presence

🇺🇸 United States97.8%

🇨🇭 Switzerland1%

🇩🇪 Germany0.6%

🇧🇷 Brazil0.6%

🇪🇸 Spain0.2%

Top 5 of 8 shown

Web traffic by country

25K monthly visits
across markets

🇺🇸 United States54.4%

🇮🇳 India23.6%

🇬🇧 United Kingdom10%

🇨🇦 Canada6.4%

🇯🇵 Japan3.6%

Top 5 markets shown

Patent intelligence

$69M patent portfolio · 41 active families

Estimated portfolio value

$69M

2.2% of market cap · 1.5× the top peer Haihe Biopharma ($45M)

41 active patent families

Where Crinetics Pharmaceuticals innovates Pharmaceutical drugDiseaseSomatostatinPharmaceutical SubstancesMolecular biology

Where Crinetics Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Crinetics Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Crinetics Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Crinetics Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Crinetics Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles